As the global economy mends, the 2021 growth of Prothrombin Complex Concentrate(PCC) will have significant change from previous year. According to our (LP Information) latest study, the global Prothrombin Complex Concentrate(PCC) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prothrombin Complex Concentrate(PCC) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Prothrombin Complex Concentrate(PCC) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Prothrombin Complex Concentrate(PCC) market, reaching US$ million by the year 2028. As for the Europe Prothrombin Complex Concentrate(PCC) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Prothrombin Complex Concentrate(PCC) players cover CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS, and Biotest, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Prothrombin Complex Concentrate(PCC) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
100IU
200IU
300IU
400IU
1000IU
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hopistial
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical